{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:31:26Z","timestamp":1792247486498,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF19OC0058484"],"award-info":[{"award-number":["NNF19OC0058484"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["9041-00291A"],"award-info":[{"award-number":["9041-00291A"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["0135-00061B"],"award-info":[{"award-number":["0135-00061B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009103","name":"Von-Behring-R\u00f6ntgen-Stiftung","doi-asserted-by":"publisher","award":["66-0004"],"award-info":[{"award-number":["66-0004"]}],"id":[{"id":"10.13039\/100009103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-69572-0","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:38:44Z","timestamp":1771324724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nanobody-based IgG simultaneously inhibit the allergenic and enzymatic activity of the dominant honeybee venom allergen"],"prefix":"10.1038","volume":"17","author":[{"given":"Josephine Baunvig","family":"Aagaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sofie Ravn","family":"Ballegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0583-2459","authenticated-orcid":false,"given":"Bjarke Krogstrup","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Dorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Verner Borg","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Lenstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"S\u00f8nderholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Miehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8721-724X","authenticated-orcid":false,"given":"Wolfgang","family":"Pf\u00fctzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3124-9998","authenticated-orcid":false,"given":"Thilo","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6292-3319","authenticated-orcid":false,"given":"Gregers Rom","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5197-7669","authenticated-orcid":false,"given":"Christian","family":"M\u00f6bs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0999-5254","authenticated-orcid":false,"given":"Edzard","family":"Spillner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"69572_CR1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1398-9995.2011.02630.x","volume":"66","author":"MB Bilo","year":"2011","unstructured":"Bilo, M. B. Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment. Allergy 66, 35\u201337 (2011).","journal-title":"Allergy"},{"key":"69572_CR2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/all.12475","volume":"69","author":"M Worm","year":"2014","unstructured":"Worm, M. et al. First European data from the network of severe allergic reactions (NORA). Allergy 69, 1397\u20131404 (2014).","journal-title":"Allergy"},{"key":"69572_CR3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1365-2222.2009.03324.x","volume":"39","author":"MB Bilo","year":"2009","unstructured":"Bilo, M. B. & Bonifazi, F. The natural history and epidemiology of insect venom allergy: clinical implications. Clin. Exp. Allergy 39, 1467\u20131476 (2009).","journal-title":"Clin. Exp. Allergy"},{"key":"69572_CR4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","volume":"18","author":"SJ Galli","year":"2012","unstructured":"Galli, S. J. & Tsai, M. IgE and mast cells in allergic disease. Nat. Med. 18, 693\u2013704 (2012).","journal-title":"Nat. Med."},{"key":"69572_CR5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/bs.ai.2018.03.002","volume":"138","author":"R Valenta","year":"2018","unstructured":"Valenta, R. et al. Molecular aspects of allergens and allergy. Adv. Immunol. 138, 195\u2013256 (2018).","journal-title":"Adv. Immunol."},{"key":"69572_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fimmu.2014.00077","volume":"5","author":"E Spillner","year":"2014","unstructured":"Spillner, E., Blank, S. & Jakob, T. Hymenoptera allergens: from venom to \u201cvenome. Front. Immunol. 5, 77 (2014).","journal-title":"Front. Immunol."},{"key":"69572_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40629-017-0014-2","volume":"26","author":"T Jakob","year":"2017","unstructured":"Jakob, T., Rafei-Shamsabadi, D., Spillner, E. & Muller, S. Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics. Allergo J. Int. 26, 93\u2013105 (2017).","journal-title":"Allergo J. Int."},{"key":"69572_CR8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1398-9995.2008.01794.x","volume":"64","author":"UR Muller","year":"2009","unstructured":"Muller, U. R., Johansen, N., Petersen, A. B., Fromberg-Nielsen, J. & Haeberli, G. Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5. Allergy 64, 543\u2013548 (2009).","journal-title":"Allergy"},{"key":"69572_CR9","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jaci.2013.10.060","volume":"133","author":"J Kohler","year":"2014","unstructured":"Kohler, J. et al. Component resolution reveals additional major allergens in patients with honeybee venom allergy. J. Allergy Clin. Immunol. 133, 1383\u20131389 (2014). 1389.e1-6.","journal-title":"J. Allergy Clin. Immunol."},{"key":"69572_CR10","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3389\/fimmu.2019.02090","volume":"10","author":"MB Pucca","year":"2019","unstructured":"Pucca, M. B. et al. Bee updated: current knowledge on bee venom and bee envenoming therapy. Front. Immunol. 10, 2090 (2019).","journal-title":"Front. Immunol."},{"key":"69572_CR11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12016-017-8597-4","volume":"54","author":"D Elieh Ali Komi","year":"2018","unstructured":"Elieh Ali Komi, D., Shafaghat, F. & Zwiener, R. D. Immunology of bee venom. Clin. Rev. Allergy Immunol. 54, 386\u2013396 (2018).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"69572_CR12","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bpj.2022.03.019","volume":"121","author":"TA Jepson","year":"2022","unstructured":"Jepson, T. A., Hall, S. C. & Chung, J. K. Single-molecule phospholipase A(2) becomes processive on melittin-induced membrane deformations. Biophys. J. 121, 1417\u20131423 (2022).","journal-title":"Biophys. J."},{"key":"69572_CR13","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1126\/science.2274788","volume":"250","author":"DL Scott","year":"1990","unstructured":"Scott, D. L., Otwinowski, Z., Gelb, M. H. & Sigler, P. B. Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue. Science 250, 1563\u20131566 (1990).","journal-title":"Science"},{"key":"69572_CR14","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1432-1033.1993.tb17870.x","volume":"213","author":"V Kubelka","year":"1993","unstructured":"Kubelka, V. et al. Primary structures of the N-linked carbohydrate chains from honeybee venom phospholipase A2. Eur. J. Biochem. 213, 1193\u20131204 (1993).","journal-title":"Eur. J. Biochem."},{"key":"69572_CR15","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jaci.2020.10.002","volume":"147","author":"P Gattinger","year":"2021","unstructured":"Gattinger, P. et al. Glycosylation enhances allergenic activity of major bee venom allergen Api m 1 by adding IgE epitopes. J. Allergy Clin. Immunol. 147, 1502\u20131504.e5 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69572_CR16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0091-6749(95)70059-5","volume":"96","author":"UR Muller","year":"1995","unstructured":"Muller, U. R. et al. Type I skin reactivity to native and recombinant phospholipase A2 from honeybee venom is similar. J. Allergy Clin. Immunol. 96, 395\u2013402 (1995).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69572_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/all.15417","volume":"78","author":"M Plum","year":"2023","unstructured":"Plum, M. et al. Structural and functional analyses of antibodies specific for modified core N-glycans suggest a role in T(H) 2 responses. Allergy 78, 121\u2013130 (2023).","journal-title":"Allergy"},{"key":"69572_CR18","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3389\/fimmu.2019.01959","volume":"10","author":"UM Sahiner","year":"2019","unstructured":"Sahiner, U. M. & Durham, S. R. Hymenoptera venom allergy: how does venom immunotherapy prevent anaphylaxis from bee and wasp stings? Front. Immunol. 10, 1959 (2019).","journal-title":"Front. Immunol."},{"key":"69572_CR19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/all.13262","volume":"73","author":"GJ Sturm","year":"2018","unstructured":"Sturm, G. J. et al. EAACI guidelines on allergen immunotherapy: hymenoptera venom allergy. Allergy 73, 744\u2013764 (2018).","journal-title":"Allergy"},{"key":"69572_CR20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000503965","volume":"181","author":"P Kranert","year":"2020","unstructured":"Kranert, P. et al. Safety and effectiveness of a 3-day rush insect venom immunotherapy protocol. Int. Arch. Allergy Immunol. 181, 111\u2013118 (2020).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"69572_CR21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/all.13077","volume":"72","author":"S Dhami","year":"2017","unstructured":"Dhami, S. et al. Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. Allergy 72, 342\u2013365 (2017).","journal-title":"Allergy"},{"key":"69572_CR22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jaci.2010.12.1080","volume":"127","author":"LK James","year":"2011","unstructured":"James, L. K. et al. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J. Allergy Clin. Immunol. 127, 509\u2013516.e1-5 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69572_CR23","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.010","volume":"140","author":"MH Shamji","year":"2017","unstructured":"Shamji, M. H. & Durham, S. R. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J. Allergy Clin. Immunol. 140, 1485\u20131498 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69572_CR24","doi-asserted-by":"crossref","unstructured":"Strobl, M. R. et al. The role of IgG(1) and IgG(4) as dominant IgE-blocking antibodies shifts during allergen immunotherapy. J. Allergy Clin. Immunol. 151, 1371\u20131378 (2023).","DOI":"10.1016\/j.jaci.2023.01.005"},{"key":"69572_CR25","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03636-8","volume":"9","author":"JM Orengo","year":"2018","unstructured":"Orengo, J. M. et al. Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement. Nat. Commun. 9, 1421 (2018).","journal-title":"Nat. Commun."},{"key":"69572_CR26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1164\/rccm.202011-4107OC","volume":"204","author":"MH Shamji","year":"2021","unstructured":"Shamji, M. H. et al. Passive prophylactic administration with a single dose of anti-Fel d 1 monoclonal antibodies REGN1908-1909 in Cat allergen-induced allergic Rhinitis: a randomized, double-blind, placebo-controlled clinical trial. Am. J. Respir. Crit. Care Med. 204, 23\u201333 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"69572_CR27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jaci.2021.05.038","volume":"149","author":"A Atanasio","year":"2022","unstructured":"Atanasio, A. et al. Targeting immunodominant Bet v 1 epitopes with monoclonal antibodies prevents the birch allergic response. J. Allergy Clin. Immunol. 149, 200\u2013211 (2022).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69572_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaci.2021.05.039","volume":"149","author":"P Gevaert","year":"2022","unstructured":"Gevaert, P. et al. Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a phase 1 study. J. Allergy Clin. Immunol. 149, 189\u2013199 (2022).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69572_CR29","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0091-6749(87)90245-4","volume":"79","author":"J Bousquet","year":"1987","unstructured":"Bousquet, J., Fontez, A., Aznar, R., Robinet-Levy, M. & Michel, F. B. Combination of passive and active immunization in honeybee venom immunotherapy. J. Allergy Clin. Immunol. 79, 947\u2013954 (1987).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69572_CR30","first-page":"1","volume":"142","author":"MH Lessof","year":"1978","unstructured":"Lessof, M. H., Sobotka, A. K. & Lichtenstein, L. M. Effects of passive antibody in bee venom anaphylaxis. Johns Hopkins Med. J. 142, 1\u20137 (1978).","journal-title":"Johns Hopkins Med. J."},{"key":"69572_CR31","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1111\/cts.13112","volume":"14","author":"MA Kamal","year":"2021","unstructured":"Kamal, M. A. et al. REGN1908-1909 monoclonal antibodies block Fel d 1 in cat allergic subjects: Translational pharmacokinetics and pharmacodynamics. Clin. Transl. Sci. 14, 2440\u20132449 (2021).","journal-title":"Clin. Transl. Sci."},{"key":"69572_CR32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","volume":"363","author":"C Hamers-Casterman","year":"1993","unstructured":"Hamers-Casterman, C. et al. Naturally occurring antibodies devoid of light chains. Nature 363, 446\u2013448 (1993).","journal-title":"Nature"},{"key":"69572_CR33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","volume":"82","author":"S Muyldermans","year":"2013","unstructured":"Muyldermans, S. Nanobodies: natural single-domain antibodies. Annu. Rev. Biochem 82, 775\u2013797 (2013).","journal-title":"Annu. Rev. Biochem"},{"key":"69572_CR34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.drudis.2016.04.003","volume":"21","author":"S Steeland","year":"2016","unstructured":"Steeland, S., Vandenbroucke, R. E. & Libert, C. Nanobodies as therapeutics: big opportunities for small antibodies. Drug Discov. Today 21, 1076\u20131113 (2016).","journal-title":"Drug Discov. Today"},{"key":"69572_CR35","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1073\/pnas.0505379103","volume":"103","author":"E De Genst","year":"2006","unstructured":"De Genst, E. et al. Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc. Natl. Acad. Sci. USA 103, 4586\u20134591 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69572_CR36","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1111\/all.15391","volume":"77","author":"JB Aagaard","year":"2022","unstructured":"Aagaard, J. B. et al. Nanobody-based human antibody formats act as IgE surrogate in hymenoptera venom allergy. Allergy 77, 2859\u20132862 (2022).","journal-title":"Allergy"},{"key":"69572_CR37","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1074\/jbc.RA117.001179","volume":"293","author":"RK Jensen","year":"2018","unstructured":"Jensen, R. K. et al. A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement. J. Biol. Chem. 293, 6269\u20136281 (2018).","journal-title":"J. Biol. Chem."},{"key":"69572_CR38","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.2274785","volume":"250","author":"DL Scott","year":"1990","unstructured":"Scott, D. L. et al. Interfacial catalysis: the mechanism of phospholipase A2. Science 250, 1541\u20131546 (1990).","journal-title":"Science"},{"key":"69572_CR39","doi-asserted-by":"crossref","first-page":"22806","DOI":"10.1074\/jbc.M800937200","volume":"283","author":"M Li","year":"2008","unstructured":"Li, M. et al. Crystal structure of a dimerized cockroach allergen Bla g 2 complexed with a monoclonal antibody. J. Biol. Chem. 283, 22806\u201322814 (2008).","journal-title":"J. Biol. Chem."},{"key":"69572_CR40","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.str.2007.09.012","volume":"15","author":"M Niemi","year":"2007","unstructured":"Niemi, M. et al. Molecular interactions between a recombinant IgE antibody and the beta-lactoglobulin allergen. Structure 15, 1413\u20131421 (2007).","journal-title":"Structure"},{"key":"69572_CR41","doi-asserted-by":"crossref","first-page":"e9037","DOI":"10.1371\/journal.pone.0009037","volume":"5","author":"J Rouvinen","year":"2010","unstructured":"Rouvinen, J. et al. Transient dimers of allergens. PLoS ONE 5, e9037 (2010).","journal-title":"PLoS ONE"},{"key":"69572_CR42","doi-asserted-by":"crossref","first-page":"12911","DOI":"10.1073\/pnas.1735525100","volume":"100","author":"J Kitaura","year":"2003","unstructured":"Kitaura, J. et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc. Natl. Acad. Sci. USA 100, 12911\u201312916 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69572_CR43","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.4049\/jimmunol.175.7.4167","volume":"175","author":"T Kawakami","year":"2005","unstructured":"Kawakami, T. & Kitaura, J. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J. Immunol. 175, 4167\u20134173 (2005).","journal-title":"J. Immunol."},{"key":"69572_CR44","doi-asserted-by":"crossref","first-page":"14706","DOI":"10.1074\/jbc.M117.793497","volume":"292","author":"C De Nardis","year":"2017","unstructured":"De Nardis, C. et al. A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G1. J. Biol. Chem. 292, 14706\u201314717 (2017).","journal-title":"J. Biol. Chem."},{"key":"69572_CR45","doi-asserted-by":"crossref","unstructured":"De Vlieger, D., Ballegeer, M., Rossey, I., Schepens, B. & Saelens, X. Single-domain antibodies and their formatting to combat viral infections. Antibodies 8, 1 (2019).","DOI":"10.3390\/antib8010001"},{"key":"69572_CR46","doi-asserted-by":"crossref","first-page":"576255","DOI":"10.3389\/fimmu.2020.576255","volume":"11","author":"S Flicker","year":"2020","unstructured":"Flicker, S., Zettl, I. & Tillib, S. V. Nanobodies-useful tools for allergy treatment? Front. Immunol. 11, 576255 (2020).","journal-title":"Front. Immunol."},{"key":"69572_CR47","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/all.15191","volume":"77","author":"I Zettl","year":"2022","unstructured":"Zettl, I. et al. Isolation of nanobodies with potential to reduce patients\u2019 IgE binding to Bet v 1. Allergy 77, 1751\u20131760 (2022).","journal-title":"Allergy"},{"key":"69572_CR48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","volume":"34","author":"I Jovcevska","year":"2020","unstructured":"Jovcevska, I. & Muyldermans, S. The therapeutic potential of nanobodies. BioDrugs 34, 11\u201326 (2020).","journal-title":"BioDrugs"},{"key":"69572_CR49","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13864","volume":"17","author":"A Deiteren","year":"2024","unstructured":"Deiteren, A. et al. A first-in-human, single and multiple dose study of lunsekimig, a novel anti-TSLP\/anti-IL-13 NANOBODY(R) compound, in healthy volunteers. Clin. Transl. Sci. 17, e13864 (2024).","journal-title":"Clin. Transl. Sci."},{"key":"69572_CR50","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/j.jmb.2018.09.002","volume":"430","author":"U Zavrtanik","year":"2018","unstructured":"Zavrtanik, U., Lukan, J., Loris, R., Lah, J. & Hadzi, S. Structural basis of epitope recognition by heavy-chain camelid antibodies. J. Mol. Biol. 430, 4369\u20134386 (2018).","journal-title":"J. Mol. Biol."},{"key":"69572_CR51","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2018.10.003","volume":"143","author":"A Zahirovic","year":"2019","unstructured":"Zahirovic, A. et al. Identification of bee venom Api m 1 IgE epitopes and characterization of corresponding mimotopes. J. Allergy Clin. Immunol. 143, 791\u2013794.e5 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69572_CR52","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.copbio.2011.06.012","volume":"22","author":"RE Kontermann","year":"2011","unstructured":"Kontermann, R. E. Strategies for extended serum half-life of protein therapeutics. Curr. Opin. Biotechnol. 22, 868\u2013876 (2011).","journal-title":"Curr. Opin. Biotechnol."},{"key":"69572_CR53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0091-6749(85)90803-6","volume":"76","author":"R Djurup","year":"1985","unstructured":"Djurup, R., Malling, H. J., Sondergaard, I. & Weeke, B. The IgE and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regimens of venom immunotherapy. J. Allergy Clin. Immunol. 76, 46\u201355 (1985).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69572_CR54","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0091-6749(92)90318-V","volume":"89","author":"ZK Peng","year":"1992","unstructured":"Peng, Z. K., Naclerio, R. M., Norman, P. S. & Adkinson, N. F. Jr. Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy. J. Allergy Clin. Immunol. 89, 519\u2013529 (1992).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69572_CR55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ebiom.2019.11.006","volume":"50","author":"J Eckl-Dorna","year":"2019","unstructured":"Eckl-Dorna, J. et al. Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG(4) response. eBioMedicine 50, 421\u2013432 (2019).","journal-title":"eBioMedicine"},{"key":"69572_CR56","doi-asserted-by":"crossref","first-page":"892631","DOI":"10.3389\/fimmu.2022.892631","volume":"13","author":"S Zinkhan","year":"2022","unstructured":"Zinkhan, S., Thoms, F., Augusto, G., Vogel, M. & Bachmann, M. F. On the role of allergen-specific IgG subclasses for blocking human basophil activation. Front. Immunol. 13, 892631 (2022).","journal-title":"Front. Immunol."},{"key":"69572_CR57","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.molimm.2004.04.018","volume":"41","author":"AM Ejrnaes","year":"2004","unstructured":"Ejrnaes, A. M., Bodtger, U., Larsen, J. N. & Svenson, M. The blocking activity of birch pollen-specific immunotherapy-induced IgG4 is not qualitatively superior to that of other IgG subclasses. Mol. Immunol. 41, 471\u2013478 (2004).","journal-title":"Mol. Immunol."},{"key":"69572_CR58","doi-asserted-by":"crossref","unstructured":"Strobl, M. R. et al. Affinity matters for IgE-blocking activity of allergen-specific antibodies. Allergy 78, 2543\u20132546 (2023).","DOI":"10.1111\/all.15746"},{"key":"69572_CR59","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jaci.2017.09.054","volume":"142","author":"L Zha","year":"2018","unstructured":"Zha, L. et al. An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor FcgammaRIIb. J. Allergy Clin. Immunol. 142, 1529\u20131536.e6 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69572_CR60","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/all.13368","volume":"73","author":"L Arzt","year":"2018","unstructured":"Arzt, L. et al. Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects. Allergy 73, 1223\u20131231 (2018).","journal-title":"Allergy"},{"key":"69572_CR61","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1398-9995.2012.02817.x","volume":"67","author":"R Erzen","year":"2012","unstructured":"Erzen, R., Kosnik, M., Silar, M. & Korosec, P. Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study. Allergy 67, 822\u2013830 (2012).","journal-title":"Allergy"},{"key":"69572_CR62","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1399-3038.2011.01233.x","volume":"23","author":"SE Zitnik","year":"2012","unstructured":"Zitnik, S. E. et al. Monitoring honeybee venom immunotherapy in children with the basophil activation test. Pediatr. Allergy Immunol. 23, 166\u2013172 (2012).","journal-title":"Pediatr. Allergy Immunol."},{"key":"69572_CR63","doi-asserted-by":"crossref","unstructured":"Paolucci, M. et al. Targeting Ara h 2 with human-derived monoclonal antibodies prevents peanut-induced anaphylaxis in mice. Allergy 78, 1605\u20131614 (2023).","DOI":"10.1111\/all.15659"},{"key":"69572_CR64","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1373\/clinchem.2006.078360","volume":"53","author":"I Braren","year":"2007","unstructured":"Braren, I. et al. Generation of human monoclonal allergen-specific IgE and IgG antibodies from synthetic antibody libraries. Clin. Chem. 53, 837\u2013844 (2007).","journal-title":"Clin. Chem."},{"key":"69572_CR65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"69572_CR66","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"69572_CR67","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"69572_CR68","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"69572_CR69","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"69572_CR70","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.157.1.221","volume":"157","author":"TW Wiegand","year":"1996","unstructured":"Wiegand, T. W. et al. High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. J. Immunol. 157, 221\u2013230 (1996).","journal-title":"J. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69572-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69572-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69572-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:02:16Z","timestamp":1771426936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69572-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69572"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69572-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"11 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Aarhus University together with the authors J.B.A., M.M. and E.S. has published a patent (WO2023170282A1) covering the molecules described in this manuscript. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1814"}}